Developer docs
API playgroundTry for free, no card

Search company profiles

Archangels

Full company profile

uuid0000xu1

Namestring
Archangels
Legal namestring
Archangel Investors Limited
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Archangels (legally Archangel Investors Limited, registered in Scotland as SC209206) is one of the UK's longest-running business angel syndicates, established in 1992 by Barry Sealey and Mike Rutterford following the syndicate's early investment in Optos (subsequently floated in 2006 and acquired by Nikon for £259M). Headquartered in Edinburgh, the syndicate operates a member-based model in which approximately 70+ Self-Certified Sophisticated or High-Net-Worth investors pool capital and expertise to take equity stakes in early-stage Scottish technology and life sciences companies. A small professional team of ~10 (including Joint Managing Directors David Ovens and Niki McKenzie, Chair Ian Macleod, and Director of New Investments Sarah Hardy) curates deal flow, performs diligence, and provides post-investment mentorship to portfolio companies.

The syndicate's core product is curated access to vetted early-stage investment opportunities rather than a software or technology product. Investment is concentrated in two verticals — disruptive technology with protectable IP, and life sciences spanning biotech, medical devices, and digital health — across an active portfolio of ~49 companies and a cumulative 80+ companies supported since inception, with £200M+ deployed. The revenue model is unconventional: Archangels generates returns through capital gains on equity exits (e.g., Touch Bionics, ZoneFox, Mpathy Medical, Blackford Analysis) and carried interest on successful realizations, rather than via product pricing or subscriptions. Member investors must meet FSMA self-certification criteria, and deal access is gated to the syndicate.

Distribution is regional, with co-investment partnerships anchoring capital availability: a £12M British Business Investments co-investment agreement (July 2023), long-standing ties with Scottish Enterprise and the Scottish National Investment Bank, and increasingly frequent co-investments with Maven VCTs and the European Space Agency. Annual reports and the investment portal at portal.archangelsonline.com serve as primary member-facing channels. Strategic positioning centers on Scotland's early-stage ecosystem, with international co-investors (e.g., PXN Ventures, European Space Agency) and an internationally-experienced Board (e.g., former Cargill APAC Chairman Ross Hamou-Jennings appointed 2026) extending the syndicate's reach without diluting its Scottish base.

Short descriptiontext

Archangels is a Scottish business angel syndicate, founded 1992 and headquartered in Edinburgh, that pools capital from 70+ sophisticated investor members to fund and mentor early-stage Scottish technology and life sciences companies, with £200M+ cumulatively deployed across 80+ portfolio businesses.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
angel investment syndicate, early-stage venture capital, seed stage investing, life sciences investing, technology startup funding
Industry1 code
1Micro-VC & Angel Funds
CodeFSANAAAIPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Investment Pools and Funds5259
SIC code1 code
  • Investment Advice6282
Product category
Angel Investment Syndicate Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns
TypeLicensing Royalties
Description

Archangels generates returns through equity investments in early-stage companies. Returns come from capital gains when portfolio companies are acquired or go public, and from carried interest on successful exits.

archangelsonline.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Archangels is a business angel syndicate that pools capital from 70+ investor members to make equity investments in early-stage Scottish technology and life sciences companies. It sources, curates, and diligencess investment opportunities, deploys syndicated capital, and provides post-investment mentorship and follow-on funding support to portfolio companies. Investors must be Self-Certified Sophisticated Investors or High Net Worth Individuals under FSMA regulations to participate.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • £200M+ invested since 1992
+2 more records
Product overview1 text field

Archangels is a Scottish business angel syndicate that provides investment syndication services rather than a traditional technology product. The core offering is a curated platform connecting investor members with early-stage technology and life science investment opportunities in Scotland. The syndicate has two primary investment focus areas: technology companies and life sciences companies. Archangels does not offer discrete software products but rather provides investment expertise, deal flow, and portfolio support services to its members.

Product and service1 record
1Archangels Investment Syndicate Services
CategoryAngel Investment Syndication
Description

Curated business angel syndication service that pools capital from 70+ investor members to make equity investments in early-stage Scottish technology and life sciences companies. Includes deal sourcing, due diligence, equity deployment, post-investment mentorship, and follow-on funding support. Investors must qualify as Self-Certified Sophisticated Investors or High Net Worth Individuals under FSMA.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeOthers
Description

Archangels is a member of UKBAA and participates in their awards and industry events.

Strategic tierMinorTypeOthers
Description

Archangels is a member of Business Angels Europe, a European network of angel investors.

Strategic tierMinorTypeOthers
Description

Archangels' Joint Managing Director Niki McKenzie chairs the Board of Angel Capital Scotland.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Edinburgh-based investment syndicate and advisory firm investing in early-stage Scottish technology businesses. Comparable as a fellow Scottish angel/advisory platform co-investing alongside Archangels.

TypeDirect peer
Description

Long-established UK business angel network affiliated with the London Stock Exchange. Comparable as a membership-based angel syndicate focused on early-stage UK investment opportunities.

TypeDirect peer
Description

Scottish business angel syndicate investing in early-stage Scottish technology and life sciences companies. Directly comparable in geography, sector focus, and syndicated angel model.

TypeDirect peer
Description

Glasgow-based angel investment syndicate investing in Scottish high-growth technology and life sciences startups. Closely comparable as a regional Scottish angel platform with overlapping deal flow.

TypeBroad incumbent
Description

Scotland's national economic development agency and a long-standing co-investment partner of Archangels. Comparable as a major capital provider in the Scottish early-stage ecosystem, though much broader in scope.

TypeBroad incumbent
Description

UK-wide fund manager with Scottish regional focus and active co-investor alongside Archangels (e.g., PowerPhotonic). Comparable as a larger institutional capital partner operating in the same Scottish ecosystem.

TypeEmerging player
Description

Scottish network connecting angel investors with early-stage companies, chaired by Archangels' Joint MD. Comparable as an ecosystem-level angel organization serving the same geography.

TypeRegional player
Description

University of Edinburgh's venture investment arm and a recurring co-investor alongside Archangels (e.g., Bioliberty, BIOCAPTIVA). Comparable as a regional institutional investor participating in Scottish early-stage rounds.

TypeBroad incumbent
Description

UK government-backed development finance institution that provided Archangels' £12M co-investment agreement. Comparable as a programmatic capital provider supporting UK angel and VC activity.

TypeDirect peer
Description

One of the UK's leading membership-based angel syndicates investing in early-stage technology and life sciences companies. Comparable in syndicate structure, member model, and sector focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment84 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Archangels

Angel Investment Syndicate Servicesarchangelsonline.com

Archangels is a Scottish business angel syndicate, founded 1992 and headquartered in Edinburgh, that pools capital from 70+ sophisticated investor members to fund and mentor early-stage Scottish technology and life sciences companies, with £200M+ cumulatively deployed across 80+ portfolio businesses.

What Archangels does

Archangels (legally Archangel Investors Limited, registered in Scotland as SC209206) is one of the UK's longest-running business angel syndicates, established in 1992 by Barry Sealey and Mike Rutterford following the syndicate's early investment in Optos (subsequently floated in 2006 and acquired by Nikon for £259M). Headquartered in Edinburgh, the syndicate operates a member-based model in which approximately 70+ Self-Certified Sophisticated or High-Net-Worth investors pool capital and expertise to take equity stakes in early-stage Scottish technology and life sciences companies. A small professional team of ~10 (including Joint Managing Directors David Ovens and Niki McKenzie, Chair Ian Macleod, and Director of New Investments Sarah Hardy) curates deal flow, performs diligence, and provides post-investment mentorship to portfolio companies.

The syndicate's core product is curated access to vetted early-stage investment opportunities rather than a software or technology product. Investment is concentrated in two verticals — disruptive technology with protectable IP, and life sciences spanning biotech, medical devices, and digital health — across an active portfolio of ~49 companies and a cumulative 80+ companies supported since inception, with £200M+ deployed. The revenue model is unconventional: Archangels generates returns through capital gains on equity exits (e.g., Touch Bionics, ZoneFox, Mpathy Medical, Blackford Analysis) and carried interest on successful realizations, rather than via product pricing or subscriptions. Member investors must meet FSMA self-certification criteria, and deal access is gated to the syndicate.

Distribution is regional, with co-investment partnerships anchoring capital availability: a £12M British Business Investments co-investment agreement (July 2023), long-standing ties with Scottish Enterprise and the Scottish National Investment Bank, and increasingly frequent co-investments with Maven VCTs and the European Space Agency. Annual reports and the investment portal at portal.archangelsonline.com serve as primary member-facing channels. Strategic positioning centers on Scotland's early-stage ecosystem, with international co-investors (e.g., PXN Ventures, European Space Agency) and an internationally-experienced Board (e.g., former Cargill APAC Chairman Ross Hamou-Jennings appointed 2026) extending the syndicate's reach without diluting its Scottish base.

Archangels firmographics

Firmographics
Name
Archangels
Legal name
Archangel Investors Limited
Website
https://archangelsonline.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
1–10 employees
Short description
Archangels is a Scottish business angel syndicate, founded 1992 and headquartered in Edinburgh, that pools capital from 70+ sophisticated investor members to fund and mentor early-stage Scottish technology and life sciences companies, with £200M+ cumulatively deployed across 80+ portfolio businesses.
Ownership category
akta.pro rank

Archangels industry classification

Industry
Product category
Angel Investment Syndicate Services
NAICS
Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
SIC
Investment Advice (6282)
akta.pro primary industry
Micro-VC & Angel Funds (FSANAAAI)

Keywords

  • Angel investment syndicate
  • Early-stage venture capital
  • Seed stage investing
  • Life sciences investing
  • Technology startup funding

Where Archangels is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Archangels business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Investment Returns: Archangels generates returns through equity investments in early-stage companies. Returns come from capital gains when portfolio companies are acquired or go public, and from carried interest on successful exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Archangels product offering

Product offering

Core offering

Archangels is a business angel syndicate that pools capital from 70+ investor members to make equity investments in early-stage Scottish technology and life sciences companies. It sources, curates, and diligencess investment opportunities, deploys syndicated capital, and provides post-investment mentorship and follow-on funding support to portfolio companies. Investors must be Self-Certified Sophisticated Investors or High Net Worth Individuals under FSMA regulations to participate.

Product overview

Archangels is a Scottish business angel syndicate that provides investment syndication services rather than a traditional technology product. The core offering is a curated platform connecting investor members with early-stage technology and life science investment opportunities in Scotland. The syndicate has two primary investment focus areas: technology companies and life sciences companies. Archangels does not offer discrete software products but rather provides investment expertise, deal flow, and portfolio support services to its members.

Differentiator

Problem solved

Functional benefit

Products and services

  • Archangels Investment Syndicate Services Curated business angel syndication service that pools capital from 70+ investor members to make equity investments in early-stage Scottish technology and life sciences companies. Includes deal sourcing, due diligence, equity deployment, post-investment mentorship, and follow-on funding support. Investors must qualify as Self-Certified Sophisticated Investors or High Net Worth Individuals under FSMA.

Quantifiable outcome

  • £200M+ invested since 1992
  • +2 more outcomes

Companies that use Archangels

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Archangels technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Archangels partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Archangels competitors and assessment

Company assessment

Direct peers

  • EOS Advisory: Edinburgh-based investment syndicate and advisory firm investing in early-stage Scottish technology businesses. Comparable as a fellow Scottish angel/advisory platform co-investing alongside Archangels.
  • London Business Angels: Long-established UK business angel network affiliated with the London Stock Exchange. Comparable as a membership-based angel syndicate focused on early-stage UK investment opportunities.
  • Equity Gap: Scottish business angel syndicate investing in early-stage Scottish technology and life sciences companies. Directly comparable in geography, sector focus, and syndicated angel model.
  • Kelvin Capital: Glasgow-based angel investment syndicate investing in Scottish high-growth technology and life sciences startups. Closely comparable as a regional Scottish angel platform with overlapping deal flow.
  • Cambridge Angels: One of the UK's leading membership-based angel syndicates investing in early-stage technology and life sciences companies. Comparable in syndicate structure, member model, and sector focus.

Broad incumbents

  • Scottish Enterprise (Scottish Investment Bank): Scotland's national economic development agency and a long-standing co-investment partner of Archangels. Comparable as a major capital provider in the Scottish early-stage ecosystem, though much broader in scope.
  • Maven Capital Partners: UK-wide fund manager with Scottish regional focus and active co-investor alongside Archangels (e.g., PowerPhotonic). Comparable as a larger institutional capital partner operating in the same Scottish ecosystem.
  • British Business Bank (British Business Investments): UK government-backed development finance institution that provided Archangels' £12M co-investment agreement. Comparable as a programmatic capital provider supporting UK angel and VC activity.

Emerging players

  • Angel Capital Scotland: Scottish network connecting angel investors with early-stage companies, chaired by Archangels' Joint MD. Comparable as an ecosystem-level angel organization serving the same geography.

Regional players

  • Old College Capital: University of Edinburgh's venture investment arm and a recurring co-investor alongside Archangels (e.g., Bioliberty, BIOCAPTIVA). Comparable as a regional institutional investor participating in Scottish early-stage rounds.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Archangels social profiles

Digital presence

Archangels financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Archangels leadership team

Management profile

Number of profiles

Profiles15 records

Archangels funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Archangels M&A and investment

M&A and investment

M&A

Investments84 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Archangels

What does Archangels do?

Archangels is a business angel syndicate that pools capital from 70+ investor members to make equity investments in early-stage Scottish technology and life sciences companies. It sources, curates, and diligencess investment opportunities, deploys syndicated capital, and provides post-investment mentorship and follow-on funding support to portfolio companies. Investors must be Self-Certified Sophisticated Investors or High Net Worth Individuals under FSMA regulations to participate.

Is Archangels a public or private company?

Archangels is a private company. It is classified as management employee owned and is currently operating.

When was Archangels founded?

Archangels was founded in 1992. It employs 1 to 10 people.

Where is Archangels based?

Archangels is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does Archangels make money?

One revenue line is on record: investment Returns.

Who are Archangels's main competitors?

Direct peers on record are EOS Advisory, London Business Angels, Equity Gap, Kelvin Capital and Cambridge Angels. Broad incumbents are Scottish Enterprise (Scottish Investment Bank), Maven Capital Partners and British Business Bank (British Business Investments). Angel Capital Scotland is listed as an emerging player. Old College Capital is listed as a regional player.

Does Archangels have an API?

No public API is recorded for Archangels.

What industry is Archangels in?

Archangels's product category is Angel Investment Syndicate Services. Its primary akta.pro industry code is FSANAAAI, Micro-VC & Angel Funds. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmagBathgate based CSignum raises £2.6m seed round backed by Archangels and PXN VenturesCSignum, a hardware startup, closed a £2.6m seed round to accelerate commercial deployment of its EM2 product family for underwater and through-ground monitoring. The funding, backed by Archangels, PXN Ventures, and others, coincides with John Nicholls' appointment as CEO. The company plans to scale manufacturing and expand across UK, US, and EU markets.InsidermediaArchangels backs Scotland’s scale-ups with £17.9m in H1Edinburgh-based angel investment syndicate Archangels leveraged £17.9m of investment in Scottish scale-ups during H1 2026, with £7.2m invested directly by its members and £10.7m in co-investment from partner investors. Key deals included University of Edinburgh spin-out Biocaptiva raising £1.58m to commercialise its liquid biopsy technology and spin-out Bioliberty securing a £6.2m Series A round co-led with the Scottish National Investment Bank. Scotland's early-stage investment market demonstrated resilience, recording a record £1.15bn raised in 2025 despite challenging global conditions.Scotland NewsEdinburgh University start-up secures £6m funding boostEdinburgh-based Earth Blox has secured £6 million in funding to help businesses assess financial costs of nature loss and climate risk. The round was led by PXN Ventures with participation from Scottish Enterprise, Archangels, and the European Space Agency, with the funds earmarked for team growth, product development, and enhanced AI-powered analysis combining satellite, environmental and portfolio data. The University of Edinburgh spin-out, which simplifies satellite image analysis through a drag-and-drop interface, recently completed a nature risk assessment project with Lloyds Banking Group covering over 1.2 million hectares of farmland.BdailyBiotech firm secures £1.58 million funding boostBIOCAPTIVA, an Edinburgh-based life sciences spin-out from the University of Edinburgh, has raised £1.58 million in a funding round led by Archangels, with participation from Old College Capital, BBI, Scottish Enterprise, and new investor EverQuest Capital Partners. The company has developed a magnetic bead-based platform called msX that extracts cell-free DNA directly from whole blood for liquid biopsy testing, and has launched its msX research kits in the US market. The funding will support further product development, with the company also appointing genetics and molecular diagnostics specialist Alan Schafer as chief technology officer.Startups Magazine2025: Archangels leveraged £41M of investment in Scottish scaleupsArchangels, an Edinburgh-based angel investment syndicate, invested a total of £41.1 million in Scottish tech and life science companies in 2025, marking a 50% increase from 2024. The investments included funding rounds for companies such as CSignum, Neuranics, and Calcivis, as well as a successful exit via the acquisition of Reactec by Ideagen.TechStartupsScottish angel syndicate Archangels backs £41M into scale-ups in 2025, up 50% year-over-yearEdinburgh-based angel investment syndicate Archangels channelled £41.1 million into Scottish scale-ups in 2025, a 50% increase from £27.3 million the prior year, with £12.8 million coming from its own members and £28.4 million from co-investors including the Investment Fund for Scotland, Scottish National Investment Bank, and Old College Capital. The year also delivered a notable exit when global compliance software firm Ideagen acquired Edinburgh-based wearable tech company Reactec, adding to approximately £40 million in returns sent to investors over the past four years. Notable portfolio funding rounds included CSignum's £6 million Series A for underwater communications technology, Neuranics' £6.1 million seed round for deep-tech semiconductor technology, and Calcivis' £3 million raise to support U.S. expansion.businessInsiderScottish nanomaterial producer secures £8.8 million fundingScottish nanomaterial producer iGii has secured £8.8 million in new funding to accelerate customer projects and expand its manufacturing capacity for its patented Gii technology. The investment round was led by the Scottish National Investment Bank with a £4 million contribution, supplemented by £4.8 million from existing shareholders Archangel Investors and Par Equity. The funds will support scaling production of diagnostic sensors and deepen research into applications such as water quality monitoring and battery storage.LinkedInBioliberty Secures £2.2M to Fund Soft Robotic Glove - ArchangelsBioliberty has secured funding led by Archangels, with participation from Eos, Old College Capital and Hanna Capital SEZC, to develop its soft robotic Lifeglov. The device, paired with a digital therapy platform, delivers tailored hand-strength exercises, monitors upper limb mobility metrics and tracks patient progress. The company is finalising the product.UKTNScottish startup raises £2m for single-use inhalerEdinburgh-based startup 1nhaler has secured a £2m investment to further develop its cardboard-based, single-use dry powder inhaler. The funding round was led by Archangels, with additional contributions from British Business Investments and Dr Yusuf Hamied of Cipla. The company intends to use the capital to partner with other firms to commercialize its environmentally friendly alternative to plastic inhalers.BusinessCloudScottish pharma company bags £2m investmentBDD, a Scottish drug formulation and clinical trials company, secured a £2m investment led by existing investors including Archangels, Scottish Enterprise, and British Business Bank. The funding will expand clinical capacity and enable Phase I First in Human trials, following an 18-month period that more than doubled revenues in 2022.